My bookmarksSign up free

Directive 2001/83/EC of the European Parliament and of the… Article 66

Article 66

1. The outer carton and the container of medicinal products containing radionuclides shall be labelled in accordance with the regulations for the safe transport of radioactive materials laid down by the International Atomic Energy Agency. Moreover, the labelling shall comply with the provisions set out in paragraphs 2 and 3. 2. The label on the shielding shall include the particulars mentioned in Article 54. In addition, the labelling on the shielding shall explain in full, the codings used on the vial and shall indicate, where necessary, for a given time and date, the amount of radioactivity per dose or per vial and the number of capsules, or, for liquids, the number of millilitres in the container. 3. The vial shall be labelled with the following information: - the name or code of the medicinal product, including the name or chemical symbol of the radionuclide, - the batch identification and expiry date, - the international symbol for radioactivity, - the name of the manufacturer, - the amount of radioactivity as specified in paragraph 2.

Read the full instrument → · Read this in context: TITLE V — LABELLING AND PACKAGE LEAFLET →

Other provisions in TITLE V — LABELLING AND PACKAGE LEAFLET

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 66 of Directive 2001/83/EC of the European Parliament and of the… (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next